Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,100 shares, a decline of 50.8% from the April 30th total of 36,800 shares. Approximately 0.6% of the company’s stock are sold short. Based on an average […]
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) will be announcing its earnings results on Wednesday, May 3rd. Aileron Therapeutics Stock Performance Shares of ALRN traded down $0.05 during midday trading on Tuesday, hitting $1.40. 4,918 shares of the company traded hands, compared to its average volume of 48,075. Aileron Therapeutics has a 52 week low of […]
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) is scheduled to announce its earnings results on Wednesday, May 3rd. Aileron Therapeutics Stock Performance ALRN stock traded down $0.05 during trading on Tuesday, hitting $1.40. 4,918 shares of the company’s stock traded hands, compared to its average volume of 48,079. Aileron Therapeutics has a 52 week low of […]
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decrease of 27.6% from the March 31st total of 35,500 shares. Based on an average daily volume of 52,100 shares, the days-to-cover ratio is […]
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decline of 27.6% from the March 31st total of 35,500 shares. Based on an average trading volume of 52,100 shares, the short-interest ratio is […]